CELC Celcuity Inc.
65.78USD-7.68%Mkt Cap: 3.22B $P/E: —1d ago
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolis…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap3.22B USD
Enterprise Value3.49B USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-177.04M USD
Revenue/Share—
Last Price65.78 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees155
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-890.63
PEG—
EV/EBITDA-16.73
EV/Revenue—
P/S—
P/B-272.99
EPS (TTM)-4.17
EPS (Forward)-0.08
52W Range
44.4220% of range151.02
52W High151.02 USD
52W Low44.42 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-176.06%
ROA-37.95%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-153.28M USD
CapEx (TTM)249.00K USD
FCF Margin—
FCF Yield-2.24%
Net Debt340.99K USD
Net Debt/EBITDA-0.00
Balance Sheet
Debt/Equity3.20
Current Ratio8.93
Quick Ratio8.68
Book Value/Sh-0.26 USD
Cash/Share15.41 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)156.91 USD
Upside (mean)+138.5%
Target Range130.00 USD – 177.00 USD
130.00+138.5% to mean177.00
# Analysts11
Ownership
Shares Out.48.93M
Float29.72M
Insiders10.23%
Institutions110.11%
Short Interest
Short Ratio14.1d
Short % Float34.83%
Short % Out.23.22%
Shares Short11.36M
Short (prev mo.)10.54M
Technical
SMA 5087.08 (-24.5%)
SMA 200104.30 (-36.9%)
Beta0.11
S&P 52W Chg16.45%
Avg Vol (30d)984.68K
Avg Vol (10d)1.18M
Technical Indicators
RSI (14)26.2
MACD-5.1710
MACD Signal-4.0141
MACD Hist.-1.1568
BB Upper92.82 USD
BB Middle80.01 USD
BB Lower67.20 USD
BB Width32.02%
ATR (14)5.074 USD
Vol Ratio (20d)2.56x